210 related articles for article (PubMed ID: 3557776)
1. Pharmaceutical promotion in Canada: convince them or confuse them.
Lexchin J
Int J Health Serv; 1987; 17(1):77-89. PubMed ID: 3557776
[TBL] [Abstract][Full Text] [Related]
2. Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin J
CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
[TBL] [Abstract][Full Text] [Related]
3. Doctors and detailers: therapeutic education or pharmaceutical promotion?
Lexchin J
Int J Health Serv; 1989; 19(4):663-79. PubMed ID: 2583883
[TBL] [Abstract][Full Text] [Related]
4. Canadian marketing codes: how well are they controlling pharmaceutical promotion?
Lexchin J
Int J Health Serv; 1994; 24(1):91-104. PubMed ID: 8150569
[TBL] [Abstract][Full Text] [Related]
5. Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines?
Lexchin J
CMAJ; 1997 Feb; 156(3):351-6. PubMed ID: 9033415
[TBL] [Abstract][Full Text] [Related]
6. A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998.
Ma J; Stafford RS; Cockburn IM; Finkelstein SN
Clin Ther; 2003 May; 25(5):1503-17. PubMed ID: 12867225
[TBL] [Abstract][Full Text] [Related]
7. The medical profession and the pharmaceutical industry: an unhealthy alliance.
Lexchin J
Int J Health Serv; 1988; 18(4):603-16. PubMed ID: 3235246
[TBL] [Abstract][Full Text] [Related]
8. Promotion of prescription drugs to consumers.
Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
[TBL] [Abstract][Full Text] [Related]
9. The federal regulation of prescription drug advertising and promotion.
Kessler DA; Pines WL
JAMA; 1990 Nov; 264(18):2409-15. PubMed ID: 2231998
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical drug promotion: how it is being practiced in India?
Lal A
J Assoc Physicians India; 2001 Feb; 49():266-73. PubMed ID: 11225144
[TBL] [Abstract][Full Text] [Related]
11. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative.
Majumdar SR; Almasi EA; Stafford RS
JAMA; 2004 Oct; 292(16):1983-8. PubMed ID: 15507584
[TBL] [Abstract][Full Text] [Related]
12. Regulating pharmaceutical advertising: what will work?
Shapiro MF
CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
[TBL] [Abstract][Full Text] [Related]
13. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada.
Desjardins JG
CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417
[TBL] [Abstract][Full Text] [Related]
14. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
[TBL] [Abstract][Full Text] [Related]
15. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
Lexchin J; Holbrook A
CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560
[TBL] [Abstract][Full Text] [Related]
16. What patients think about promotional activities of pharmaceutical companies in Turkey.
Semin S; Güldal D; Ozçakar N; Mevsim V
Pharm World Sci; 2006 Aug; 28(4):199-206. PubMed ID: 17066242
[TBL] [Abstract][Full Text] [Related]
17. Complaints about Violations of Voluntary and Pharmaceutical Industry-Run Medicine Promotion Codes in Canada.
Lexchin J
Int J Soc Determinants Health Health Serv; 2023 Oct; 53(4):518-527. PubMed ID: 36938584
[TBL] [Abstract][Full Text] [Related]
18. The influences of drug companies' advertising programs on physicians.
Güldal D; Semin S
Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183
[TBL] [Abstract][Full Text] [Related]
19. Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999.
Palmer JA; Timm AR; Neumann PJ
J Manag Care Pharm; 2008 Oct; 14(8):749-55. PubMed ID: 18983204
[TBL] [Abstract][Full Text] [Related]
20. Opioid promotion in Canada: A narrative review.
Lexchin J
Indian J Med Ethics; 2024; IX(2):135-142. PubMed ID: 38755771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
